408 related articles for article (PubMed ID: 29967007)
41. APOE Isoforms Control Pathogenic Subretinal Inflammation in Age-Related Macular Degeneration.
Levy O; Lavalette S; Hu SJ; Housset M; Raoul W; Eandi C; Sahel JA; Sullivan PM; Guillonneau X; Sennlaub F
J Neurosci; 2015 Oct; 35(40):13568-76. PubMed ID: 26446211
[TBL] [Abstract][Full Text] [Related]
42. ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and Aβ Secretion.
Huang YA; Zhou B; Wernig M; Südhof TC
Cell; 2017 Jan; 168(3):427-441.e21. PubMed ID: 28111074
[TBL] [Abstract][Full Text] [Related]
43. Apolipoprotein E isoforms and regulation of the innate immune response in brain of patients with Alzheimer's disease.
Keene CD; Cudaback E; Li X; Montine KS; Montine TJ
Curr Opin Neurobiol; 2011 Dec; 21(6):920-8. PubMed ID: 21907569
[TBL] [Abstract][Full Text] [Related]
44. A unifying hypothesis of Alzheimer's disease. IV. Causation and sequence of events.
Heininger K
Rev Neurosci; 2000; 11 Spec No():213-328. PubMed ID: 11065271
[TBL] [Abstract][Full Text] [Related]
45. Apolipoprotein E-mediated Modulation of ADAM10 in Alzheimer's Disease.
Shackleton B; Crawford F; Bachmeier C
Curr Alzheimer Res; 2017; 14(6):578-585. PubMed ID: 28164773
[TBL] [Abstract][Full Text] [Related]
46. Evidence in support of chromosomal sex influencing plasma based metabolome vs APOE genotype influencing brain metabolome profile in humanized APOE male and female mice.
Shang Y; Mishra A; Wang T; Wang Y; Desai M; Chen S; Mao Z; Do L; Bernstein AS; Trouard TP; Brinton RD
PLoS One; 2020; 15(1):e0225392. PubMed ID: 31917799
[TBL] [Abstract][Full Text] [Related]
47. Central and Peripheral Mechanisms in ApoE4-Driven Diabetic Pathology.
Koren-Iton A; Salomon-Zimri S; Smolar A; Shavit-Stein E; Dori A; Chapman J; Michaelson DM
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075060
[TBL] [Abstract][Full Text] [Related]
48. ApoE: crossroads between Alzheimer's disease and atherosclerosis.
Stojakovic T; Scharnagl H; März W
Semin Vasc Med; 2004 Aug; 4(3):279-85. PubMed ID: 15630629
[TBL] [Abstract][Full Text] [Related]
49. Human apolipoprotein E isoforms differentially affect bone mass and turnover in vivo.
Dieckmann M; Beil FT; Mueller B; Bartelt A; Marshall RP; Koehne T; Amling M; Ruether W; Cooper JA; Humphries SE; Herz J; Niemeier A
J Bone Miner Res; 2013 Feb; 28(2):236-45. PubMed ID: 22991192
[TBL] [Abstract][Full Text] [Related]
50. ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease.
Li Y; Macyczko JR; Liu CC; Bu G
Neurobiol Aging; 2022 Jul; 115():20-28. PubMed ID: 35453035
[TBL] [Abstract][Full Text] [Related]
51. Targeting Apolipoprotein E for Alzheimer's Disease: An Industry Perspective.
Suidan GL; Ramaswamy G
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052389
[TBL] [Abstract][Full Text] [Related]
52. APOE and Alzheimer's disease: Pathologic clues from transgenic Drosophila melanogaster.
Haddadi M; Haghi M; Rezaei N; Kiani Z; Akkülah T; Celik A
Arch Gerontol Geriatr; 2024 Aug; 123():105420. PubMed ID: 38537387
[TBL] [Abstract][Full Text] [Related]
53. Calcium-dependent cytosolic phospholipase A
Wang S; Li B; Solomon V; Fonteh A; Rapoport SI; Bennett DA; Arvanitakis Z; Chui HC; Sullivan PM; Yassine HN
Mol Neurodegener; 2022 Jun; 17(1):42. PubMed ID: 35705959
[TBL] [Abstract][Full Text] [Related]
54. Hyperlipidemia in APOE2 transgenic mice is ameliorated by a truncated apoE variant lacking the C-terminal domain.
Gerritsen G; Kypreos KE; van der Zee A; Teusink B; Zannis VI; Havekes LM; van Dijk KW
J Lipid Res; 2003 Feb; 44(2):408-14. PubMed ID: 12576523
[TBL] [Abstract][Full Text] [Related]
55. Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex.
Arold S; Sullivan P; Bilousova T; Teng E; Miller CA; Poon WW; Vinters HV; Cornwell LB; Saing T; Cole GM; Gylys KH
Acta Neuropathol; 2012 Jan; 123(1):39-52. PubMed ID: 22020632
[TBL] [Abstract][Full Text] [Related]
56. Independent APOE4 knock-in mouse models display reduced brain APOE protein, altered neuroinflammation, and simplification of dendritic spines.
Sepulveda J; Luo N; Nelson M; Ng CAS; Rebeck GW
J Neurochem; 2022 Nov; 163(3):247-259. PubMed ID: 35838553
[TBL] [Abstract][Full Text] [Related]
57. Impact of the apolipoprotein E polymorphism, age and sex on neurogenesis in mice: pathophysiological relevance for Alzheimer's disease?
Koutseff A; Mittelhaeuser C; Essabri K; Auwerx J; Meziane H
Brain Res; 2014 Jan; 1542():32-40. PubMed ID: 24140109
[TBL] [Abstract][Full Text] [Related]
58. APOE2 Exacerbates TDP-43 Related Toxicity in the Absence of Alzheimer Pathology.
Meneses AD; Koga S; Li Z; O'Leary J; Li F; Chen K; Murakami A; Qiao W; Kurti A; Heckman MG; White L; Xie M; Chen Y; Finch NA; Lim MJ; Delenclos M; DeTure MA; Linares C; Martin NB; Ikezu TC; van Blitterswijk MM; Wu LJ; McLean PJ; Rademakers R; Ross OA; Dickson DW; Bu G; Zhao N
Ann Neurol; 2023 Apr; 93(4):830-843. PubMed ID: 36546684
[TBL] [Abstract][Full Text] [Related]
59. Opposing effects of apoE2 and apoE4 on microglial activation and lipid metabolism in response to demyelination.
Wang N; Wang M; Jeevaratnam S; Rosenberg C; Ikezu TC; Shue F; Doss SV; Alnobani A; Martens YA; Wren M; Asmann YW; Zhang B; Bu G; Liu CC
Mol Neurodegener; 2022 Nov; 17(1):75. PubMed ID: 36419137
[TBL] [Abstract][Full Text] [Related]
60. Macrophage-mediated degradation of beta-amyloid via an apolipoprotein E isoform-dependent mechanism.
Zhao L; Lin S; Bales KR; Gelfanova V; Koger D; Delong C; Hale J; Liu F; Hunter JM; Paul SM
J Neurosci; 2009 Mar; 29(11):3603-12. PubMed ID: 19295164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
